| Accepted Name | |||||||
|---|---|---|---|---|---|---|---|
| 15-hydroxyprostaglandin dehydrogenase (NAD(+)). | |||||||
| Alternative Name(s) | |||||||
| 15-hydroxyprostaglandin dehydrogenase. | |||||||
| Reaction catalysed | |||||||
| (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate + NAD(+) <=> (5Z,13E)-11-alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NADH | |||||||
| Comment(s) | |||||||
| Acts on prostaglandins E(2), F(2-alpha) and B(1), but not on prostaglandin D(2) (cf. EC 1.1.1.196 and EC 1.1.1.197). | |||||||
| Cross-references | |||||||
| PROSITE | PDOC00060 | ||||||
| BRENDA | 1.1.1.141 | ||||||
| EC2PDB | 1.1.1.141 | ||||||
| ExplorEnz | 1.1.1.141 | ||||||
| PRIAM enzyme-specific profiles | 1.1.1.141 | ||||||
| KEGG Ligand Database for Enzyme Nomenclature | 1.1.1.141 | ||||||
| IUBMB Enzyme Nomenclature | 1.1.1.141 | ||||||
| IntEnz | 1.1.1.141 | ||||||
| MEDLINE | Find literature relating to 1.1.1.141 | ||||||
| MetaCyc | 1.1.1.141 | ||||||
| UniProtKB/Swiss-Prot |
| ||||||